Postdoctoral Fellowship in the Health Economics of Genomic Medicine
Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences
June 26, 2018
Vancouver, British Columbia
Full Time - Fellowship
Health Economics/Outcomes Research
GenCOUNSEL is a project funded by Genome Canada that is led by international researchers in genomics, genetic counselling, ethics, health services implementation and health economics. These researchers will help determine the most effective and efficient methods for the clinical implementation of genomic medicine/whole genome sequencing.
The GenCounsel team is seeking a Post-Doctoral Fellow for the Health Economics and Health Services Research components of the project which include:
The development of a workforce model for genetics services that projects the future demand for and supply of genome-wide sequencing (GWS) and genetic counselling in Canada;
Cost-effectiveness and budget impact analyses of a utilization management service in provincial genetics laboratories;
An evaluation of alternative models for the delivery of pre-GWS genetic counselling services (e.g., face-to-face, telehealth, online decision aids); and
A discrete choice experiment to elicit patient/parent preferences for the method of delivery of genetic counselling to support GWS.
The results of the GenCOUNSEL project will contribute significantly to policy development related to the provision of clinical genetics services in Canada, and the future integration of GWS into clinical practice.
Applicants must have:
A PhD in epidemiology, health economics, health services research, health policy, or a related discipline;
Previous health economics and/or health services research experience preferred; and
A desire to take on leadership responsibilities by leading the development of specific research initiatives within the scope of the broader project.
The successful applicant will be responsible for activities related to the health economics and health services research components of the project. This position will enable leadership opportunities for the right candidate, and may allow for the development of new research methods and techniques related to the project to be spearheaded by the Fellow.
In addition, the Fellow will have a unique opportunity to be mentored by, and collaborate with, leading researchers and healthcare providers at UBC, BC Children’s and Women’s Hospitals, McGill University, and the Memorial University of Newfoundland.
This position is best suited to an individual who can work independently and as part of a team, and provide supervision and/or mentorship to junior researchers.
About GenCOUNSEL and GWS:
Genome-wide sequencing (GWS) is a powerful new genetic test that analyzes a person’s entire genetic make-up to diagnose the cause of genetic disorders, identify risk factors for serious diseases, and tailor pharmaceutical therapies to individual patients. GWS generates unique implementation issues, however, as it may diagnose disorders or disease risk factors that are unrelated to the original reason for testing. In addition, it can generate complex results that are difficult for non-expert healthcare providers to interpret. Currently, this technology is not routinely available in Canada, but because of its diagnostic capability, the utilization of GWS is expected to increase significantly by 2030.
To ensure a sustainable implementation of GWS, it is imperative to identify the types of patients and indications for which the use of GWS is most cost-effective. In addition, as more patients and families consider GWS as a test option, the demand for decisional support (e.g., genetic counselling, bioinformatics, medical genetics) for patients, families, and non-specialist healthcare providers is likely to increase dramatically. Given the current genetic counselling capacity in Canada, this is likely to lead to significant unmet need for GWS decision support if cost-effective and scalable approaches to delivering genetic counselling are not developed and implemented. Thus, the objective of the GenCOUNSEL project is to generate the evidence necessary to support policy development and efficient clinical implementation of GWS to facilitate equal access for all Canadians.
Housed within The University of British Columbia’s Faculty of Pharmaceutical Sciences, the Collaboration for Outcomes Research and Evaluation (CORE) is an academic research group established in 2000 by Dr. David Fielding. In 2004, leadership of the research group came under the direction of Dr. Carlo Marra, and Dr. Larry Lynd, with Dr. Lynd appointed as Director in 2014.
The mission of CORE is to improve health?care related outcomes for drug therapy through the application of the best in research, education and practice enhancement strategies. CORE strives to provide evidence which will maximize the clinical, quality of life, and economic benefits of drug therapy, while minimizing associated risks. This is achieved through in dependent research and research collaborations with pharmaceutical and health outcomes researchers throughout North America and Europe.
Applications will be accepted until the position is filled.
Preferred start date is November 1st 2018 but is negotiable. The applicant will be required to provide a rationale and justification for applying for this Fellowship and outline their specific objectives for the duration of the fellowship.
Interested and qualified applicants should send their curriculum vitae, a description of relevant research experience and most significant research accomplishments, a statement of research interests, and contact information for three referees via email to:
Project Manager, Collaboration for Outcomes Research and Evaluation (CORE)
Faculty of Pharmaceutical Sciences, University of British Columbia
2405 Wesbrook Mall Vancouver, BC V6T 1Z3
Equity and diversity are essential to academic excellence. An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged. We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, or Indigenous person.
All qualified candidates are encouraged to apply; however Canadians and permanent residents will be given priority.
About Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences
Housed within The University of British Columbia’s Faculty of Pharmaceutical Sciences, the Collaboration for Outcomes Research and Evaluation (CORE) is an academic research group established in 2000 by Dr. David Fielding. In 2004, leadership of the research group came under the direction of Dr. Carlo Marra, and Dr. Larry Lynd, with Dr. Lynd appointed as Director in 2014. Through their vision for becoming leaders in evidence based evaluation, they endeavor to develop CORE in terms of both research and training in pharmaceutical outcomes. In this regard, CORE continues to evolve and develop as evidenced by our many accomplishments. More than $7 million in research funding has been accrued; a multidisciplinary group of researchers with expertise in clinical pharmacy, pharmacoepidemiology, health economics, health services research, program evaluation and health promotion research has been assembled; and numerous graduate students have been recruited.
The mission of CORE is to improve health?care related outcomes for drug therapy through the application of the best in research, education and practice enhancement strategies. CORE strives to provide evidence which will maximize the cl...inical, quality of life, and economic benefits of drug therapy, while minimizing associated risks. This is achieved through in dependent research and research collaborations with pharmaceutical and health outcomes researchers throughout North America and Europe.